Gefitinib
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67184-0531 -
Package NDC
67184-0531-1 -
Package NDC
67184-0531-2 -
Package NDC
67184-0531-3 -
Application number
ANDA211591 -
SPL ID
8aa73f33-2813-4dfa-939f-e4291081449a -
SPL set ID
0afc12dd-12f8-4def-9027-f38412a862b9 -
UNII
S65743JHBS -
RxCUI
349472
What the source publishes
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Active ingredients
- Gefitinib
- Form
- TABLET, COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Gefitinib",
"splId": "8aa73f33-2813-4dfa-939f-e4291081449a",
"labels": [
{
"setId": "0afc12dd-12f8-4def-9027-f38412a862b9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0afc12dd-12f8-4def-9027-f38412a862b9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0afc12dd-12f8-4def-9027-f38412a862b9"
}
],
"routes": [
"ORAL"
],
"labeler": "Qilu Pharmaceutical Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, COATED in 1 BOTTLE (67184-0531-1)",
"package_ndc": "67184-0531-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20230213"
},
{
"sample": false,
"description": "500 TABLET, COATED in 1 BOTTLE (67184-0531-2)",
"package_ndc": "67184-0531-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20230213"
},
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK",
"package_ndc": "67184-0531-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20230213"
}
],
"productId": "67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a",
"useDomain": "unknown",
"dosageForm": "TABLET, COATED",
"productNdc": "67184-0531",
"deaSchedule": null,
"genericName": "Gefitinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GEFITINIB",
"strength": "250 mg/1"
}
],
"applicationNumber": "ANDA211591",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230213",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000175076"
],
"upc": [
"0367184053124"
],
"unii": [
"S65743JHBS"
],
"rxcui": [
"349472"
],
"spl_set_id": [
"0afc12dd-12f8-4def-9027-f38412a862b9"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Protein Kinase Inhibitors [MoA]"
],
"manufacturer_name": [
"Qilu Pharmaceutical Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a"